• Vancomycin hydrochloride: Assay Workflows

  2026-10-01

  Build more interpretable Gram-positive susceptibility and resistance assays with Vancomycin hydrochloride, using mechanism-matched controls, time-course sampling, and disciplined stock preparation. A semi-mechanistic resistance-modeling study also shows why endpoint MICs alone can miss adaptive changes, offering a practical framework for stronger experimental design.

• SETD7 Depletion Promotes White Fat Browning

  2026-10-01

  The 2026 Cell Death & Differentiation study identifies SETD7 as a negative regulator of inguinal white adipose tissue thermogenesis. Using mouse, cellular, and RNA-sequencing models, the authors connect SETD7 depletion to the Adcy7–Sirt1–Creb1 axis, enhanced beige adipocyte activity, higher energy expenditure, and protection from diet-induced metabolic dysfunction.

• Vancomycin hydrochloride: Practical Assay Workflows

  2026-09-30

  Vancomycin hydrochloride provides a mechanistically defined benchmark for Gram-positive susceptibility testing, resistance studies, selective workflows, and translational infection models. This guide connects practical preparation and assay design with KR-12 antimicrobial-peptide research while emphasizing controls, orthogonal readouts, and troubleshooting.

• Nerve-Driven HDAC1 Controls Axolotl Limb Regeneration

  2026-09-30

  Wang and colleagues show that nerve input regulates a biphasic increase in HDAC1 during axolotl limb regeneration, particularly in the wound epidermis. Pharmacological inhibition, denervation, and growth-factor rescue experiments position HDAC1 as a functional link between neural signals, blastema formation, and regenerative outgrowth.

• Vancomycin hydrochloride in Resistance Assays

  2026-09-29

  Build more reproducible susceptibility, resistance, and infection-model workflows with Vancomycin hydrochloride, a mechanism-defined glycopeptide antibacterial agent. This guide connects practical assay controls with KR-12-inspired experimental design, while separating evidence-backed applications from workflow recommendations.

• PKM2 inhibitor (compound 3k) Workflow Guide

  2026-09-29

  Build reproducible cancer-metabolism assays around PKM2 inhibitor (compound 3k), from DMSO stock preparation to viability, glycolysis, and xenograft study design. Its value extends beyond oncology: the compound can also serve as a mechanistic probe for PKM2-dependent immune-metabolic reprogramming when paired with the reference study’s macrophage workflow.

• DMG-PEG2000-N3 for Reliable Cell Assays

  2026-09-28

  Learn how DMG-PEG2000-N3 (SKU M2012) can support reproducible bioconjugation, liposome formulation, and cell-based viability workflows. This scenario-driven guide covers controls, stock preparation, assay interpretation, and practical supplier-selection criteria without overstating product-specific biological validation.

• Praeruptorin A: Applied Research Workflows

  2026-09-28

  Praeruptorin A offers researchers a multi-pathway tool for studying iron-dependent cell injury, inflammatory barrier damage, and tumor-cell migration. This workflow-focused guide explains how to select models, build interpretable dose-response experiments, and separate established findings from practical optimization suggestions.

• BHQ and Calcium-Store Perturbation: An Assay Logic Guide

  2026-09-27

  2,5-di-tert-butylbenzene-1,4-diol (BHQ) is more than a SERCA inhibitor: it is a way to probe how calcium-store disruption propagates into cell behavior. This guide focuses on interpreting time-dependent responses, with the 2025 HSC-mobilization study as a case study in connecting perturbation to mechanism.

• Sulfo-NHS-Biotin in Cell Assay Workflows

  2026-09-26

  Learn where Sulfo-NHS-Biotin (SKU A8001) can strengthen cell-surface labeling workflows—and where it should not be mistaken for a viability reagent. This scenario-based guide covers compatibility, handling, interpretation, and practical supplier selection with product specifications and a linked single-cell profiling dissertation.

• Daphnepedunin A Targets Cdc42 in Kidney Fibrosis

  2026-09-25

  The study identifies the natural diterpenoid daphnepedunin A as an antifibrotic lead and uses thermal proteome profiling to identify Cdc42 as its direct target. In renal fibroblast and unilateral ureteral obstruction models, the findings connect reduced Cdc42 activity to lower PKCζ–GSK-3β signaling, increased β-catenin degradation, and attenuation of kidney fibrosis.

• Clathrin-Mediated Entry of Type III Grass Carp Reovirus

  2026-09-25

  Wang et al. used inhibitor analysis, electron microscopy, and quantitative PCR to show that type III grass carp reovirus GCRV104 depends on clathrin-associated, dynamin-dependent entry and endosomal acidification in CIK cells. The study also found that latrunculin B did not inhibit infection under the tested conditions, an important qualification when interpreting actin perturbation in viral-entry experiments.

• FPH1 for Functional Hepatocyte Expansion

  2026-09-24

  FPH1 (BRD-6125) helps researchers evaluate hepatocyte proliferation alongside functional markers, rather than relying on cell counts alone. This workflow covers primary human hepatocyte culture and iPSC-derived hepatocyte-like cells, with practical dosing, readouts, and troubleshooting guidance.

• 2-D08 for SUMOylation Pathway Assays

  2026-09-24

  Use 2-D08 as a mechanistic probe to test substrate-level SUMO transfer—not as a stand-in for SENP2 or a validated BPD treatment. This guide outlines a cautious dose-ranging workflow, controls, and readouts for connecting SUMOylation changes to FUNDC1-dependent mitophagy.

• Anti-RPS6 Antibody: Practical Assay Guidance

  2026-09-23

  Learn how to use the Anti-RPS6 (7B10) Mouse Monoclonal Antibody, SKU MA4974, as an orthogonal protein readout in cell proliferation and cancer biology studies. The guide covers assay fit, optimization, interpretation limits, and practical product-selection criteria grounded in the available product information and literature.

8528 records 1/569 page Next 12345 下5页 Last page